Ex-vivo response to blood products and haemostatic agents after paediatric cardiac surgery.
Hvas AM, Andreasen JB, Christiansen K, Ravn HB
Purpose
The purpose of this paper was to determine the effects of undergoing cardiac surgery and the ex vivo addition of haemostatic agents on hematology and coagulation parameters in pediatric blood specimens.
Conclusion
Specimens that were collected after patients had undergone cardiac surgery had significantly decreased platelet counts, fibrinogen concentrations, prothrombin time (PT), clot propagation maximum velocity (MaxVel), and maximum clot firmness (MCF), and significantly increased thrombin time (TT), D-dimer concentration, clot initiation time, and termination (t), MaxVel compared to those specimens collected before surgery. Activated partial thromboplastin time (aPTT) and factor XIII were not significantly affected by undergoing cardiac surgery. Of the 6 haemostatic agents tested for the ability to reverse coagulation profiles to preoperative values by ex vivo addition, pooled platelets showed the largest effect.
Studies (1)
Purpose
The purpose of this study was to determine the effects of undergoing cardiac surgery and the ex vivo addition of haemostatic agents on hematology and coagulation parameters in 54 pediatric blood specimens. Specimens were obtained before heparinization and after the end of cardiopulmonary bypass and Protaminsulfate administration into EDTA tubes for platelet counts and into citrate tubes for the measurement of aPTT, PT, TT, fibrinogen, D-dimer, and thromboelastometric whole blood coagulation profiles.
Summary of Findings
Specimens that were collected after patients had undergone cardiac surgery had significantly decreased platelet counts (p<0.0001), fibrinogen concentrations (p=0.002), PT (p<0.0001), clot propagation MaxVel (p<0.001), and MCF (p<0.001), and significantly increased TT (p<0.0001), D-dimer concentration (p<0.0001), clot initiation time (p=0.008), and t, MaxVel (p=0.004) compared to those specimens collected before surgery. aPTT and factor XIII were not significantly affected by undergoing cardiac surgery. Of the 6 haemostatic agents tested for the ability to reverse coagulation profiles to preoperative values by ex vivo addition, pooled platelets showed the largest effect with recombinant factor VIIa also altering clot initiation, propagation, termination, and MCF. Tranexamic acid and factor XIII had the least effects on coagulation profiles.
Biospecimens
FluidBloodPreservation Types
None (Fresh)Diagnoses
Other diagnosesCardiovascular DiseasePlatforms
Cell count/volumeHematology/ auto analyzerGlycoproteinHematology/ auto analyzerMorphologyHematology/ auto analyzerPeptideHematology/ auto analyzerProteinHematology/ auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Atrial septal defectComplete atrioventricular canalCongenital heart defectHypoplastic left heart syndromeOther reasons for elective cardiac surgeryPulmonary atresiaTetralogy of FallotTransposition of the great arteriesVentricular septal defectBiospecimen Acquisition Time of biospecimen collection PostoperativePreoperativeBiospecimen Aliquots and Components Biospecimen components Factor XIIIFibrinogen concentrateFresh frozen plasmaPooled plateletsRecombinant factor VIIaTranexamic acid